Clinical trials of the two Indian vaccine candidates—the mRNA jab from Gennova and the Receptor Binding Protein (RBD) vaccine by Biological E—are expected to speed up after the government agreed to supply doses of Covishield vaccines to these companies for a comparator study, people aware of the development said.

Both companies had been stuck with their vaccine development as they were unable to get doses from Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin to proceed with their late-stage trials.
https://www.livemint.com/science/health/clinical-trials-of-gennova-...